Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
about
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.Artemisinin: A Panacea Eligible for Unrestrictive Use?The Promise of Systems Biology Approaches for Revealing Host Pathogen Interactions in Malaria.Screening a protein kinase inhibitor library against Plasmodium falciparum.Malaria parasite evolution in a test tube.Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics.Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance.Using in Vitro Evolution and Whole Genome Analysis To Discover Next Generation Targets for Antimalarial Drug Discovery.Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum.Malaria Surveillance - United States, 2015.Plasmodial Kinase Inhibitors: License to Cure?Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis.Transcriptomic Studies of Malaria: a Paradigm for Investigation of Systemic Host-Pathogen InteractionsEmerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquineAntimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a studyEvidence for Regulation of Hemoglobin Metabolism and Intracellular Ionic Flux by the Plasmodium falciparum Chloroquine Resistance TransporterScreening for potential prophylactics targeting sporozoite motility through the skinChallenges and recent progress in drug discovery for tropical diseases
P2860
Q46250299-2C7F0B6D-64AC-4E40-845B-9D8B031A2B99Q47096125-C15C66B3-83B5-48ED-8CF7-F47738C7DB1DQ47133377-AB319DDF-E46D-4DC5-90EB-7BC51A1C2F85Q47162276-B0CE042A-C9EE-47BB-9313-CFAA862F8FF2Q48021778-6BFCF39A-BD6C-4547-8BE3-9D14F71FF814Q48021791-EB0647C9-EB18-44D2-82D4-808334DCA095Q48023117-11D41727-36EE-4C0E-B1E0-EF199D029F70Q49927350-A4E696E2-C134-4FCA-8631-20B133492FBCQ52646479-5A94370E-F066-4ECD-BE2E-7F4689E2FEF2Q54107801-F4761B7E-2BB8-402C-A11C-0353E145599EQ54978870-43D48273-9820-4CDA-994C-7E441ABFC766Q55000698-96AB8E63-B49B-4BD7-8256-0792905AF696Q55106515-9649FB0D-77F5-4C6B-A4F9-6E16E34E2EDCQ56342194-1FF0D1D6-384E-484A-AF24-0BFF6C74A4CEQ56352603-53B6B728-12E2-4951-BA14-B9FD6BE1B9F9Q58751587-71170402-0A25-4902-A7FA-C4239B124345Q58781866-75D3C76F-4197-4DEC-8840-4A61DE5C99D1Q59073293-78778845-EDC3-45BC-A0E4-DAE2C0885FE0
P2860
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Antimalarial drug resistance: ...... arasite biology to the clinic.
@en
type
label
Antimalarial drug resistance: ...... arasite biology to the clinic.
@en
prefLabel
Antimalarial drug resistance: ...... arasite biology to the clinic.
@en
P2860
P356
P1433
P1476
Antimalarial drug resistance: ...... arasite biology to the clinic.
@en
P2093
Benjamin Blasco
Didier Leroy
P2860
P2888
P304
P356
10.1038/NM.4381
P407
P577
2017-08-01T00:00:00Z